MedTrace Logo

The Effects of Contact Lenses With UV/HEV-Filter on Visual Function

NCT05601544 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2025-04-27

Study results available
· View outcomes & findings →

Summary

This is a 2-phase, single-site, non-dispensing, randomized, controlled, double-masked, 2x2 crossover study to objectively measure potential benefits of a new UV/HEV filter using psychophysical testing techniques.

Conditions

  • Visual Acuity

Interventions

DEVICE

ACUVUE OASYS 1-Day

Sphere CONTROL

DEVICE

ACUVUE OASYS MAX 1-Day

Sphere TEST

DEVICE

ACUVUE OASYS Multifocal

Multifocal CONTROL

DEVICE

ACUVUE OASYS MAX 1-Day Multifocal

Multifocal TEST

DEVICE

ACUVUE OASYS 1-Day for Astigmatism

Toric CONTROL

DEVICE

senofilcon A based contact lens (toric) with new UV/HEV filter

Toric TEST

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Vision Care, Inc. Clinical Trial · Johnson & Johnson Vision Care, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2023-11-17
Completion
2023-11-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05601544 on ClinicalTrials.gov